Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of GSK's GSK-1070806?
GSK-1070806 is a monoclonal antibody commercialized by GSK, with a leading Phase II program in Crohn's Disease (Regional Enteritis). According...
Data Insights
GSK-1070806 by GSK for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
GSK-1070806 is under clinical development by GSK and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to GlobalData,...